封面
市場調查報告書
商品編碼
1442014

陰道吊帶市場- 按產品(經閉孔、無張力陰道吊帶、迷你吊帶)、失禁類型(壓力型、急迫型、混合型)、類型(中尿道型、傳統型)、最終用途(醫院、診所、 ASC) - 全球預測, 2024 - 2032

Vaginal Slings Market - By Product (Transobturator, Tension-free Vaginal Tape, Mini-Slings), Incontinence type (Stress, Urge, Mixed), Type (Midurethral, Traditional), End-use (Hospitals, Clinics, ASC) - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於人們對治療選擇的認知不斷提高,加上手術技術和材料的進步,全球陰道吊帶市場將從 2024 年到 2032 年以 9% 的CAGR成長。隨著患者對微創手術及其益處的了解越來越多,對骨盆底疾病有效解決方案的需求也隨之增加。此外,吊帶設計和材料的不斷創新可以提高患者的治療效果和滿意度。隨著醫療保健提供者擴大採用這些技術以及尋求改善生活品質的患者,陰道吊帶產業將顯著擴張。

例如,2022年10月,一種治療女性壓力性尿失禁的創新療法Urolon在英國首次亮相。這種持續時間約為 20 分鐘的微創治療適合在醫院或診所進行。此次推出擴大了女性壓力性尿失禁的治療選擇範圍,有助於市場的多元化和成長。

陰道吊帶產業根據產品、失禁類型和地區進行分類。

由於其治療壓力性尿失禁和骨盆腔器官脫垂的功效,到 2032 年,無張力陰道膠帶細分市場將佔據顯著的市場佔有率。無張力陰道膠帶手術侵入性極小,成功率高,提供患者有效且持久的解決方案。此外,技術進步改進了膠帶設計和材料,改善了患者的治療效果。隨著醫療保健提供者擴大採用這種方法,並且患者尋求微創治療方案,無張力陰道吊帶細分市場將在陰道吊帶行業中佔據最大佔有率。

由於其針對壓力性尿失禁和急迫性尿失禁的多功能治療方法,到 2032 年,混合性尿失禁領域的陰道吊帶市佔率將大幅上升。由於大量患者出現混合症狀,因此對有效、全面的解決方案的需求很高。吊帶設計的技術進步專門針對混合性失禁,為患者提供更好的生活品質。隨著醫療保健提供者優先考慮量身定做的治療方案以及患者尋求全面護理,混合性失禁細分市場將成為陰道吊帶市場前景的重要參與者。

受尿失禁治療意識增強、老年人口增加和醫療基礎設施改善等因素的推動,亞太地區陰道吊帶產業到 2032 年將錄得顯著的複合CAGR。此外,該地區龐大的人口基數和不斷成長的可支配收入也促進了市場的成長。技術進步和有利的政府措施將進一步推動陰道吊帶術在該地區的採用。綜合這些因素,亞太地區將成為陰道吊帶產業的關鍵貢獻者。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 尿失禁(UI)盛行率增加
      • 老年人口不斷增加
      • 手術技術不斷進步
      • 對骨盆底疾病及其治療方案的認知不斷提高
    • 產業陷阱與挑戰
      • 陰道吊帶手術費用高
      • 安全性和有效性問題
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 報銷場景
  • 未來市場趨勢
  • 缺口分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 經閉孔吊帶
  • 無張力陰道吊帶
  • 迷你吊帶

第 6 章:市場估計與預測:按失禁類型,2018 年 - 2032 年

  • 主要趨勢
  • 壓力性尿失禁
  • 急迫性尿失禁
  • 混合性失禁

第 7 章:市場估計與預測:按類型,2018 - 2032

  • 主要趨勢
  • 尿道中段吊帶
  • 傳統吊帶

第 8 章:市場估計與預測:按最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 診所
  • 門診手術中心

第 9 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • A.M.I. GmbH
  • B. Braun Melsungen AG
  • Betatech Medical
  • Boston Scientific Corporation
  • Caldera Medical
  • Coloplast Corp
  • Cousin Surgery
  • Johnson & Johnson Services, Inc.
  • Lotus Surgicals
  • Neomedic International
  • Promedon S.A.
  • UroCure
簡介目錄
Product Code: 3335

Global Vaginal Slings Market will expand at a 9% CAGR from 2024 to 2032, attributed to increasing awareness of treatment options coupled with advancements in surgical techniques and materials. As patients become more informed about minimally invasive procedures and their benefits, demand for effective solutions for pelvic floor disorders rises. Moreover, continuous innovation in sling design and materials enhances patient outcomes and satisfaction. With healthcare providers increasingly adopting these techniques and patients seeking improved quality of life, the vaginal slings industry will expand significantly.

For instance, in October 2022, Urolon, an innovative therapy for female stress urinary incontinence, debuted in the UK. This minimally invasive treatment with a duration of approximately 20 minutes is suitable for administration in either a hospital or clinic setting. The launch expands the range of treatment options available for female stress urinary incontinence, contributing to the diversification and growth of the market.

The vaginal slings industry is classified based on product, incontinence type, and region.

The tension-free vaginal tape segment will capture noteworthy market share through 2032, propelled by its efficacy in treating stress urinary incontinence and pelvic organ prolapse. With minimal invasiveness and high success rates, tension-free vaginal tape procedures offer patients effective and long-lasting solutions. Moreover, technological advancements have improved tape design and materials, enhancing patient outcomes. As healthcare providers increasingly adopt this method and patients seek minimally invasive treatment options, the tension-free vaginal tape segment will secure the largest share in the vaginal slings industry.

The vaginal slings market share from the mixed incontinence segment will experience a substantial upswing by 2032 due to its versatile treatment approach addressing both stress and urge urinary incontinence. With a significant patient population experiencing mixed symptoms, the demand for effective and comprehensive solutions is high. Technological advancements in sling design cater specifically to mixed incontinence, offering patients an improved quality of life. As healthcare providers prioritize tailored treatment options and patients seek comprehensive care, the mixed incontinence segment will stand as a prominent player in the vaginal slings market outlook.

Asia Pacific vaginal slings industry will record a remarkable CAGR by 2032, fueled by factors such as increasing awareness of urinary incontinence treatments, a rising geriatric population, and improving healthcare infrastructure. Moreover, the region's large population base and growing disposable income contribute to market growth. Technological advancements and favorable government initiatives will further propel the adoption of vaginal sling procedures in the region. With these factors combined, Asia Pacific will emerge as the pivotal contributor to the vaginal slings industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Base estimates & workings
  • 1.5 Forecast calculations
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of urinary incontinence (UI)
      • 3.2.1.2 Growing geriatric population
      • 3.2.1.3 Increasing advancements in surgical techniques
      • 3.2.1.4 Rising awareness of pelvic floor disorders and their treatment options
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of vaginal sling procedure
      • 3.2.2.2 Safety and efficacy concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Transobturator slings
  • 5.3 Tension-free vaginal tape slings
  • 5.4 Mini-slings

Chapter 6 Market Estimates and Forecast, By Incontinence Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Stress incontinence
  • 6.3 Urge incontinence
  • 6.4 Mixed incontinence

Chapter 7 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Midurethral sling
  • 7.3 Traditional sling

Chapter 8 Market Estimates and Forecast, By End-use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 A.M.I. GmbH
  • 10.2 B. Braun Melsungen AG
  • 10.3 Betatech Medical
  • 10.4 Boston Scientific Corporation
  • 10.5 Caldera Medical
  • 10.6 Coloplast Corp
  • 10.7 Cousin Surgery
  • 10.8 Johnson & Johnson Services, Inc.
  • 10.9 Lotus Surgicals
  • 10.10 Neomedic International
  • 10.11 Promedon S.A.
  • 10.12 UroCure